Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Oncology Stories

2014-04-08 23:29:27

CHAMPS Oncology will be observing the 18th annual National Cancer Registrars Week (NCRW) April 7-11, 2014. Cleveland, OH (PRWEB) April 08, 2014 CHAMPS Oncology will be observing the 18th annual National Cancer Registrars Week (NCRW) April 7-11, 2014. This celebration of the cancer registry profession was founded by the National Cancer Registrars Association (NCRA). With more than 35 years in the cancer registry profession, CHAMPS Oncology is honored to join NCRA in celebrating cancer...

2014-04-08 23:27:16

Australian researchers say a serious complication associated with treating excess lung fluid in mesothelioma can be treated with radiotherapy. Raleigh, NC (PRWEB) April 08, 2014 A new study finds that mesothelioma metastasis (spreading) along the path of an indwelling pleural catheter usually responds to treatment without having to removing the catheter. Click here to read the findings, which have just been posted on the Surviving Mesothelioma website. Researchers with the Sir Charles...

2014-04-08 23:27:10

Dr. Babak Larian, Director of the CENTER for Advanced Parotid Surgery in Beverly Hills, responds to a new study that shows skin cancer survivors may have an increased risk of developing other cancers. Beverly Hills, CA (PRWEB) April 08, 2014 In response to a new study conducted by researchers at the University of Melbourne in Australia, Dr. Babak Larian of the CENTER for Advanced Parotid Surgery in Beverly Hills recently discussed how skin cancer may be linked to salivary gland cancer....

2014-04-08 12:32:28

Champions TumorGrafts(TM) Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma HACKENSACK, N.J., April 8, 2014 /PRNewswire/ -- Data published in Cancer show the use of personalized patient-derived xenografts, or mouse avatars, accurately predicted treatment efficacy in all evaluated patients with advanced sarcoma. The results support the predictive capabilities of Champions TumorGrafts®, developed by Champions Oncology (OTC:...

2014-04-08 12:31:36

Community Leaders throughout the North Bay Area Assemble to Join LLS in the Fight against Blood Cancers SANTA ROSA, Calif., April 8, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter is launching its 2014 North Bay Man & Woman of the Year (MWOY) fundraising campaign, enlisting influential and compassionate community leaders as candidates competing to raise funds for blood cancer research and cures. In its second year, the North...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...

2014-04-08 12:26:38

RESTON, Va., April 8, 2014 /PRNewswire-USNewswire/ -- inPractice® Resources, LLC, a subsidiary of Clinical Care Options (CCO), today announced the launch of a first-of-its kind education and reference tool dedicated to the needs of all nurses who provide care for patients with cancer. inPractice® Oncology Nursing is a point-of-care tool that combines high-quality nursing-focused content, oncology-specific clinical decision support, patient education, and professional development...

2014-04-08 12:07:17

-NRAS is one of the most studied cancer-related genes. -This study found that the gene produces five variants, not just one form as thought. -The finding might help improve drugs for cancers that involve NRAS. A new study shows that a gene discovered 30 years ago and now known to play a fundamental role in cancer development produces five different gene variants (called isoforms), rather than just the one original form, as thought. The study of the NRAS gene by researchers at The Ohio...

2014-04-08 08:31:39

OICR's catalyst grant enables WaveCheck to open first partner site at MD Anderson Cancer Center in May TORONTO, April 8, 2014 /PRNewswire/ - People with breast cancer are a step closer to knowing if their tumour is responding to chemotherapy at the start of treatment, thanks to a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR). The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over...

2014-04-08 08:31:34

SUNNYVALE, Calif., April 8, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA), based on data from the randomized, multi-center, open-label Phase III RESONATE(TM) study, PCYC-1112, a head-to-head comparison of single agent IMBRUVICA(TM) (ibrutinib) versus ofatumumab in 391 patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), who...